Standing 219 centimeters tall, it can dribble fluidly and boasts a shot that professionals would envy. During its official presentation in Tokyo, Toyota’s humanoid CUE7 robot sank a flawless basket in front of thousands of fans, proving the massive strides Japanese engineers have made in advanced machine motor skills.
Anthropic has developed an artificial intelligence model with unprecedented hacking capabilities. For security reasons, the technology won’t hit the open market – instead, access has been granted to a select group of US tech titans. This situation exposes a glaring flaw in European regulations: while the US builds a digital fortress, EU policymakers are trying to regulate a technology they cannot even access.
The ten-day Artemis II mission – the first crewed flight beyond low Earth orbit in over half a century – has proven that NASA’s technology is ready for the next giant leap. It stands as a culmination of engineering triumphs, human emotion, and tough decisions that pave the way not only to the Moon but ultimately to Mars.
Pharmaceutical giant GSK has presented promising Phase I clinical trial results for its targeted ADC therapy (mocertatug rezetecan). The novel drug, aimed at the B7-H4 antigen, demonstrates exceptionally high efficacy against treatment-resistant ovarian cancer and advanced endometrial cancer, paving the way for large-scale Phase III trials later this year.